CA2079803A1 - Utilisation de trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou d'affections virales - Google Patents

Utilisation de trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou d'affections virales

Info

Publication number
CA2079803A1
CA2079803A1 CA002079803A CA2079803A CA2079803A1 CA 2079803 A1 CA2079803 A1 CA 2079803A1 CA 002079803 A CA002079803 A CA 002079803A CA 2079803 A CA2079803 A CA 2079803A CA 2079803 A1 CA2079803 A1 CA 2079803A1
Authority
CA
Canada
Prior art keywords
group
formulation
optionally
carminic acid
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002079803A
Other languages
English (en)
Inventor
Washington Odur Ayuko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RADOPATH Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909007453A external-priority patent/GB9007453D0/en
Priority claimed from GB909012166A external-priority patent/GB9012166D0/en
Priority claimed from GB919103075A external-priority patent/GB9103075D0/en
Application filed by Individual filed Critical Individual
Publication of CA2079803A1 publication Critical patent/CA2079803A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/15Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
CA002079803A 1990-04-03 1991-04-03 Utilisation de trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou d'affections virales Abandoned CA2079803A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB909007453A GB9007453D0 (en) 1990-04-03 1990-04-03 Tumour therapy
GB9007453.5 1990-04-03
GB909012166A GB9012166D0 (en) 1990-05-31 1990-05-31 Hydrazine derivatives for cancer therapy
GB9012166.6 1990-05-31
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use
GB9103075.9 1991-02-13

Publications (1)

Publication Number Publication Date
CA2079803A1 true CA2079803A1 (fr) 1991-10-04

Family

ID=27265028

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002079803A Abandoned CA2079803A1 (fr) 1990-04-03 1991-04-03 Utilisation de trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou d'affections virales

Country Status (11)

Country Link
EP (1) EP0524212A1 (fr)
JP (1) JPH06501449A (fr)
AU (1) AU662883B2 (fr)
BR (1) BR9106310A (fr)
CA (1) CA2079803A1 (fr)
FI (1) FI924475A0 (fr)
HU (1) HUT62785A (fr)
LV (1) LV10574B (fr)
MC (1) MC2246A1 (fr)
NO (1) NO923824L (fr)
WO (1) WO1991015200A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) * 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
US5412123A (en) * 1993-02-08 1995-05-02 Glycomed Incorporated Anthraquinone and anthracene derivatives as inhibitors of the cell-adhesion molecules of the immune system
GB2312375B (en) * 1993-05-21 1998-02-25 Radopath Ltd Agents for treatment of cancer
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
GB9310520D0 (en) 1993-05-21 1993-07-07 Radopath Ltd Arylating agents
DE69519722D1 (de) * 1994-03-17 2001-02-01 Radopath Pharmaceuticals Inter Wirkstof gegen viren und krebs
WO1996029067A1 (fr) * 1995-03-17 1996-09-26 Radopath Limited Agents antiviraux et anticancereux
GB9615619D0 (en) * 1996-03-18 1996-09-04 Radopath Ltd Costimulation of TcR/CD3-induced T-Lymphocytes
AU1903699A (en) * 1997-12-08 1999-06-28 Glycomed Incorporated Disalicylate analog based sialyl lewisx mimetics
JP2021530605A (ja) * 2018-07-17 2021-11-11 ピリ アントラキノン系誘導体及び着色剤としてのそれらの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032659A (en) * 1969-03-20 1977-06-28 American Home Products Corporation Method of viral chemoprophylaxis
CA1262864A (fr) * 1982-09-17 1989-11-14 Clarence D. Cone Methode de production d'une oncolyse
FR2622445B1 (fr) * 1987-10-30 1990-07-27 Pasteur Institut Application de groupes nitrophenyles a la stimulation des capacites d'incorporation d'un medicament dans les cellules sensibles de l'hote

Also Published As

Publication number Publication date
NO923824D0 (no) 1992-10-01
NO923824L (no) 1992-11-26
MC2246A1 (fr) 1993-03-25
HU9203148D0 (en) 1992-12-28
LV10574A (lv) 1995-04-20
LV10574B (en) 1995-08-20
FI924475A (fi) 1992-10-05
AU662883B2 (en) 1995-09-21
FI924475A0 (fi) 1992-10-05
BR9106310A (pt) 1993-04-20
EP0524212A1 (fr) 1993-01-27
JPH06501449A (ja) 1994-02-17
WO1991015200A2 (fr) 1991-10-17
WO1991015200A3 (fr) 1992-03-05
AU7560491A (en) 1991-10-30
HUT62785A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
EP0196415B1 (fr) Trichostatines A et C comme agents anti-tumeurs
CN101589026B (zh) 治疗脑神经胶质瘤的方法
NZ240487A (en) Formulations comprising trinitrobenzene derivative and optionally a quinone
CA2079803A1 (fr) Utilisation de trinitrobenzenes ou d&#39;acide carminique pour le traitement du cancer ou d&#39;affections virales
TR201808687T4 (tr) Düşük vi̇zkozi̇teli̇ gli̇kosami̇nogli̇kanlardan oluşan bi̇leşi̇mler ve söz konusu bi̇leşi̇mi̇n, kroni̇k si̇sti̇t tedavi̇si̇nde kullanimi
US6288045B1 (en) Epithelial cell cancer drug
US5891454A (en) Anti-cancer drug and special tumor necrotizing agent
US20040101573A1 (en) Injectable composition for cancer treatment
EP0137807A1 (fr) Composition antivirale et son procede d&#39;administration
CN102470146A (zh) 血管新生控制组合物以及控制血管新生的方法
EA000879B1 (ru) Инфузионный раствор &#34;реамберин&#34;
Teunis et al. Acute methemoglobinemia and hemolytic anemia due to toluidine blue
JP4348084B2 (ja) 抗癌薬
Perpich et al. Effect of urethane, hydroxyurethane and hydroxyurea on synthesis of nucleic acid
笠原善弥 Bone invasion-targeted chemotherapy with a novel anionic platinum complex (3Pt) for oral squamous cell carcinoma
LT3173B (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
RU2192870C1 (ru) Антивирусная композиция, способ получения ее активной компоненты и способ лечения вич-инфицированных больных этой композицией
RU2094056C1 (ru) Вещество, обладающее антигипоксической активностью
SU357985A1 (fr)
CN112094322A (zh) His-Gly-Lys修饰的甲氨蝶呤,其合成,抗肿瘤活性和应用
CN112094320A (zh) His-Gly-Glu修饰的甲氨蝶呤,其合成,抗肿瘤活性和应用
Janek The biological effects of urethane
CN106344571A (zh) Atropurpuran衍生物组合物在抗急性肾衰药物中的应用
HRP920891A2 (en) Quinone preparation
WO2013070988A2 (fr) Procédé de traitement de l&#39;ostéosarcome

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued